This indicator measures the percentage of patients with diabetes, age 18 or over, who have had a diabetic foot ulcer risk assessment using a standard, validated tool within the past 12 months.

Retired

Quality Improvement Plans (QIPs)

Effective

Process

This is an additional QIP indicator for FY 2018/19. Current performance reporting period: last consecurtive 12 months. This indicator is recommended for quality statement #1 in the Quality Standard for Diabetic Foot Ulcers. Please see the standard for more detailed information about risk assessment for diabetic foot ulcers. The Quality Standard includes standardized tools to guide clinical practice. Standard validated tools These should address the following components, at a minimum: Examination of both legs and feet (including the spaces between the toes) for evidence of: • Neuropathy (e.g., using a 10 g monofilament) • Ulceration • Callus • Skin temperature (a difference of 2°C or 3–4°F between the two feet could indicate infection, issues with vascular supply, or deep trauma) • Structural abnormalities and deformities • Charcot arthropathy • Swelling of the calf, thigh, or ankles • Skin colour changes • Skin and nail changes • Range of motion, gait, and footwear • Palpation of foot pulses (top of foot and inner ankle) Asking about previous foot ulcers and amputations Ankle-brachial pressure index or toe-brachial pressure index at regular intervals to screen for peripheral arterial disease (calcified arteries may falsely elevate results in people with diabetes, so results should be interpreted carefully) One example of a standard validated tool is Inlow’s 60-second Diabetic Foot Screen Tool. This indicator was retired in the 2019/20 QIP.

04/03/2019 10:08:00